SCHEMBL6160675

SCHEMBL6160675

CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)OC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 1/20 0.47
EPHX2 P34913 1/20 0.45
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
UCHL1 P09936 1/20 0.42
HSD17B10 Q99714 2/20 0.42
KLK7 P49862 1/20 0.42
HSD11B1 P28845 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7359670 0.91 ALDH1A1 (0.50) ALDH1A1LMNAMAPTEPHX2NPC1
SCHEMBL29223888 0.81 CYP1A2 (0.49) ALDH1A1LMNAMAPTCYP1A2CYP2D6
SCHEMBL28606669 0.80 NPC1 (0.55) ALDH1A1LMNAMAPTEPHX2NPC1
SCHEMBL10722455 0.79 GAA (0.45) ALDH1A1LMNAMAPTEPHX2NPC1
SCHEMBL13230378 0.79 NPC1 (0.49) ALDH1A1LMNAMAPTEPHX2NPC1
SCHEMBL2439825 0.79 NPC1 (0.49) ALDH1A1LMNAMAPTEPHX2NPC1
SCHEMBL6160995 0.79 CYP1A2 (0.44) ALDH1A1LMNAMAPTCYP1A2CYP2D6
SCHEMBL20400750 0.79 CYP1A2 (0.44) ALDH1A1LMNAMAPTCYP1A2CYP2D6
SCHEMBL21530375 0.79 CYP1A2 (0.44) ALDH1A1LMNAMAPTCYP1A2CYP2D6
SCHEMBL10722390 0.79 ALDH1A1 (0.42) ALDH1A1LMNAMAPTEPHX2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129070-A4 NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS BRISTOL MYERS SQUIBB CO (US) 2005-03-02 EP disclosed
EP-1129070-A1 NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-09-05 EP disclosed
US-6228872-B1 PEPTIDE-PROLYL ISOMERASE AND ROTAMASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2001-05-08 US disclosed
WO-2000027811-A1 NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-05-18 WO disclosed